Amgen stock trades steady as investors digest Repatha growth and oncology pipeline

Amgen stock trades steady as investors digest Repatha growth and oncology pipeline  ad-hoc-news.de

Summary aggregated from ad-hoc-news.de's public RSS feed. The full reporting belongs to ad-hoc-news.de — please read it on their site.